Vitamin B12 deficiency commonly presents with a mix of hematologic and neurologic symptoms that can develop gradually and be mistaken for other conditions. Recognizing these signs early matters because some neurologic damage may become irreversible if treatment is delayed. Clinical descriptions and patient guidance from Mayo Clinic Staff, Mayo Clinic and the Office of Dietary Supplements, National Institutes of Health outline the typical patterns seen in practice and in population studies.
Typical clinical signs
Fatigue and weakness are among the most frequent complaints, often reflecting macrocytic anemia, where red blood cells are larger and fewer than normal. Patients may describe shortness of breath, palpitations, or a pale, slightly jaundiced complexion as anemia progresses. Changes in the mouth such as a smooth, sore tongue (glossitis) and recurrent mouth ulcers are also reported and can precede more obvious blood-test abnormalities.
Neurologic symptoms can be prominent and sometimes more specific. Numbness, tingling, and a “pins and needles” sensation in the hands and feet indicate peripheral neuropathy, while more advanced involvement causes balance problems, difficulty walking, and reduced coordination from spinal cord dysfunction. Cognitive effects range from mild memory problems and difficulty concentrating to mood changes and, in severe or prolonged cases, dementia-like symptoms. Neurologist and researcher Ralph Carmel, Mount Sinai School of Medicine has documented how these neurologic manifestations may occur with or without marked anemia, underscoring the need to consider vitamin B12 status in unexplained neurologic syndromes.
Causes and at-risk groups
Causes include inadequate dietary intake, impaired absorption, and medical or surgical conditions that interfere with vitamin B12 uptake. Strictly plant-based diets that exclude animal-source foods lack naturally occurring vitamin B12 unless fortified foods or supplements are used. Autoimmune pernicious anemia and atrophic gastritis reduce intrinsic factor or stomach acid needed for absorption, and gastrointestinal surgery such as gastric bypass can remove tissue necessary for B12 uptake. Certain medications, notably long-term proton pump inhibitors and metformin, are associated with reduced B12 absorption, as described by Mayo Clinic Staff, Mayo Clinic. Subclinical deficiency can be hard to detect because early symptoms are nonspecific and laboratory markers may lag clinical signs.
Consequences and social context
Untreated deficiency can lead to permanent neurologic injury, persistent gait disturbance, and chronic neuropathic pain. Biochemical markers such as elevated methylmalonic acid or homocysteine often confirm deficiency and guide treatment decisions recommended by the Office of Dietary Supplements, National Institutes of Health. Cultural and territorial factors influence risk: communities with limited access to animal-source foods, people following traditional or economic diets low in animal products, and older adults with age-related gastric changes are disproportionately affected. Public health approaches such as food fortification, targeted screening for high-risk groups, and culturally appropriate education about supplementation can mitigate these risks, especially in regions where dietary patterns or healthcare access increase vulnerability. Timely recognition and replacement therapy are key to preventing lasting harm.